These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15498058)

  • 21. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.
    Wilhelmus KR; Abshire RL; Schlech BA
    Arch Ophthalmol; 2003 Sep; 121(9):1229-33. PubMed ID: 12963604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin monotherapy and bacterial keratitis.
    Katz HR
    Ophthalmology; 1999 Oct; 106(10):1853-4. PubMed ID: 10519570
    [No Abstract]   [Full Text] [Related]  

  • 23. A longitudinal study of trends in keratitis in Australia.
    Green M; Apel A; Stapleton F
    Cornea; 2008 Jan; 27(1):33-9. PubMed ID: 18245964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania.
    Ni N; Nam EM; Hammersmith KM; Nagra PK; Azari AA; Leiby BE; Dai Y; Cabrera FA; Ma JF; Lambert CE; Honig SE; Rapuano CJ
    Cornea; 2015 Mar; 34(3):296-302. PubMed ID: 25603231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of chloramphenicol use and the effect on corneal scrape results in bacterial keratitis.
    Pearce F; Wong N; Chan E
    Clin Exp Ophthalmol; 2016 Dec; 44(9):868-869. PubMed ID: 27549348
    [No Abstract]   [Full Text] [Related]  

  • 26. Infectious keratitis in South Australia: emerging resistance to cephazolin.
    Leibovitch I; Lai TF; Senarath L; Hsuan J; Selva D
    Eur J Ophthalmol; 2005; 15(1):23-6. PubMed ID: 15751235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cultures in the management of ulcerative keratitis.
    Levey SB; Katz HR; Abrams DA; Hirschbein MJ; Marsh MJ
    Cornea; 1997 Jul; 16(4):383-6. PubMed ID: 9220233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of bacterial corneal ulcers at tertiary centres in Vancouver, B.C.
    Termote K; Joe AW; Butler AL; McCarthy M; Blondeau JM; Iovieno A; Holland SP; Yeung SN
    Can J Ophthalmol; 2018 Aug; 53(4):330-336. PubMed ID: 30119785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Microbiological and Antibiotic Sensitivity Patterns in Infectious Keratitis: 10-Year Experience in Mexico City.
    Hernandez-Camarena JC; Graue-Hernandez EO; Ortiz-Casas M; Ramirez-Miranda A; Navas A; Pedro-Aguilar L; Lopez-Espinosa NL; Gaona-Juarez C; Bautista-Hernandez LA; Bautista-de Lucio VM
    Cornea; 2015 Jul; 34(7):778-85. PubMed ID: 25811724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiological profile of corneal ulcer cases diagnosed in a tertiary care ophthalmological institute in Nepal.
    Suwal S; Bhandari D; Thapa P; Shrestha MK; Amatya J
    BMC Ophthalmol; 2016 Nov; 16(1):209. PubMed ID: 27899093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial corneal ulcer: a multivariate study.
    Wang AG; Wu CC; Liu JH
    Ophthalmologica; 1998; 212(2):126-32. PubMed ID: 9486553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric microbial keratitis in Taiwan: clinical and microbiological profiles, 1998-2002 versus 2008-2012.
    Lee YS; Tan HY; Yeh LK; Lin HC; Ma DH; Chen HC; Chen SY; Chen PY; Hsiao CH
    Am J Ophthalmol; 2014 May; 157(5):1090-6. PubMed ID: 24487048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study.
    Ting DSJ; Ho CS; Cairns J; Elsahn A; Al-Aqaba M; Boswell T; Said DG; Dua HS
    Br J Ophthalmol; 2021 Mar; 105(3):328-333. PubMed ID: 32580955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploratory Use of Fluorescent SmartProbes for the Rapid Detection of Microbial Isolates Causing Corneal Ulcer.
    Gunasekaran R; Lalitha P; Megia-Fernandez A; Bradley M; Williams RL; Dhaliwal K; Prajna NV; Mills B
    Am J Ophthalmol; 2020 Nov; 219():341-350. PubMed ID: 32574778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The patterns of in vitro antimicrobial susceptibility and resistance of bacterial keratitis isolates in Glasgow, United Kingdom.
    Amer Awan M; Reeks G; Rahman MQ; Butcher I; Ramaesh K
    Clin Exp Optom; 2010 Sep; 93(5):354-9. PubMed ID: 20831515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cultures in the management of ulcerative keratitis.
    McLeod SD
    Cornea; 1997 Jul; 16(4):381-2. PubMed ID: 9220232
    [No Abstract]   [Full Text] [Related]  

  • 40. Laboratory Results, Epidemiologic Features, and Outcome Analyses of Microbial Keratitis: A 15-Year Review From St. Louis.
    Hsu HY; Ernst B; Schmidt EJ; Parihar R; Horwood C; Edelstein SL
    Am J Ophthalmol; 2019 Feb; 198():54-62. PubMed ID: 30308206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.